MedPath

The impact of sleep disorders in patients with type 2 diabetes

Not Applicable
Completed
Conditions
Type 2 diabetes mellitus
Nutritional, Metabolic, Endocrine
Registration Number
ISRCTN12361838
Lead Sponsor
niversity of Birmingham
Brief Summary

2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/33752759/ (added 23/08/2022) 2024 Results article in https://doi.org/10.5664/jcsm.11020 (added 07/02/2024)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
312
Inclusion Criteria

Potential participants will be considered eligible for registration into the study if they:
1. Are =18 years old
2. Have Type 2 Diabetes
3. Have an eGFR (MDRD-4) =15 mL/min/1.73 m2 in last 3 months
4. Have an ESS <11

Potential participants will be considered eligible for randomisation into the RCT if the patient:
1. Is willing to be randomised to CPAP or no CPAP
2. Has a AHI =10

Exclusion Criteria

Potential participants will be excluded from the study if they:
1. Have Type 1 diabetes
2. Have known OSA, active malignancy or chronic kidney disease from reasons other than diabetes
3. Are receiving chemotherapy, immunosuppressant drugs or home oxygen treatment
4. Have a history of recurrent hospital admissions due to infective exacerbation of a respiratory condition
5. Have received contrast imaging within the last two months
6. Are pregnant
7. Are intending to undergo bariatric surgery during the study duration
8. Are unable to comply with the study protocol
9. Are unable to give informed consent
10. Are a professional driver, operator of heavy machinery and/or working at high altitude
11. Have a history of falling asleep whilst driving within last two years

After the home-based sleep study, potential participants will be excluded from the RCT if they:
1. Have a resting oxygen saturation < 90% (as detected during the sleep assessment recording) or have central apnoeas > 5/ hour

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath